An electrical & electronics engineer by qualification, Shikha Sinha has been working in the research and content domains for quite a while. Currently penning down informative pieces for page125.org, Shikha is also an active contributor on a variety of business portals spanning healthcare, ICT, renewables, etc. While she isn’t harnessing the power of the pen, Shikha loves to cook, read, and travel. She can be contacted at- [email protected] | https://twitter.com/shikhas999/
Henry Schein Inc. a global distributor of medical & dental supplies, has reportedly announced that it has acquired Lighthouse 360, a dental-practice software creator based in Georgia, through its joint venture Henry Schein One. Incidentally, the JV had been formed with the California-based software company, …
Medtronic PLC has reportedly announced results from its landmark clinical trial WRAP-IT which exhibited that TYRX™ Absorbable Antibacterial Envelope reduces the risk of serious infections by 40 percent and pocket infections by 61 percent, in individuals with cardiac implantable electronic devices as compared to standard-of-care …
Biohaven recently announced the expanded data from the Phase IIb/III long-term extension study of troriluzole, with its comparison to coordinated natural history cohort Biohaven Pharmaceutical Holding Company Ltd., a U.S.-based clinical-stage biopharmaceutical company, has made it to the front page with the enrollment of its …
Hemlibra is the first new class treatment for people suffering from acute haemophilia A without factor VIII inhibitors Its approval was given on the basis of favorable results from pivotal HAVEN 3 and HAVEN 4 studies Swiss based healthcare giant Roche AG has recently announced …
The research collaboration pact is aimed at identifying unique small molecule leads for targets of interest HitGen would apply its high-grade technology platform to find unique leads for SPARC Sun Pharma Advanced Research Company (SPARC), the research arm of India-based multinational drug manufacturer Sun Pharmaceutical …
FDA authenticates study protocol, giving go-ahead for GENFIT to begin a Phase II clinical trial in pediatric NASH. Elafibranor, the foremost molecule with positive outcomes on registered endpoints in Phase 2b clinical trials in adult NASH to be assessed in pediatric NASH. A 12 week …
A business unit of Precision Medicine Group, Precision for Medicine, has hit the headlines for announcing the acquisition of SimplicityBio, extending artificial intelligence capabilities to its QuartzBio™, a multiomic informatics and data integration platform. According to sources close to the development, the introduction of an …
The amount raised in the latest financing round brings the total capital raised by the company within a year to $222 million. Proceeds from the Series B financing round would be going towards the development of its next-gen CRISPR technologies & its array of base …
As a part of an expanded collaboration, GeoVax Labs Inc., an American biotechnology company and Leidos Inc., a scientific research company, have reportedly announced the development of malaria vaccine candidates. The USAID (United States Agency for International Development) MVDP (Malaria Vaccine Development Program) is reported …